Biotech Acasti Announces Preliminary Topline Results Met All Outcome Measures in the Pharmacokinetic Bridging Study for GTX-102, the Company’s Drug Candidate for the Treatment of Ataxia Telangiectasia December 28, 2022
Biotech Ampio Pharmaceuticals Regains Compliance with NYSE American Continued Listing Standards December 27, 2022
Biotech ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Eiger BioPharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important January 9 Deadline in Securities Class Action – EIGR December 27, 2022
Biotech Acer Therapeutics and Relief Therapeutics Announce U.S. FDA Approval of OLPRUVA(TM) for Patients with Urea Cycle Disorders December 27, 2022
Biotech Beat the Market the Zacks Way: Boeing, General Electric, AmerisourceBergen, Kimberly-Clark in Focus December 27, 2022
Biotech ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Eiger BioPharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – EIGR December 24, 2022
Biotech ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Eiger BioPharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EIGR December 23, 2022
Search
